Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome?

Reflections

Like Comment
Related Content

Volume 113, Issue 1, Pages 87–88

Authors:

Sushila Arya, M.D., Karl R. Hansen, M.D., Ph.D., Robert A. Wild, M.D., M.P.H., Ph.D.

Abstract:

Reflections on "Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial" by Li et al.


Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.